High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals

Myeloperoxidase Targets Apolipoprotein A-I, the Major High Density Lipoprotein Protein, for Site-Specific Oxidation in Human Atherosclerotic Lesions

(2012) Baohai Shao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fibrin Clot Structure and Function

(2011) Anetta Undas et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Anti-oxidant properties of high-density lipoprotein and atherosclerosis

(2010) Eugene A Podrez   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

High-density lipoproteins, platelets and the pathogenesis of atherosclerosis

(2010) Jerzy-Roch Nofer et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd–Chiari syndrome

(2010) Simone Talens et al.   JOURNAL OF HEPATOLOGY

Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia

(2010) F. E. VAN DEN BOOGAARD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives

(2009) A. Undas et al.   BLOOD

Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men

(2009) Mirjam E. Meltzer et al.   BRITISH JOURNAL OF HAEMATOLOGY

Fibrin clot properties in acute ischemic stroke: relation to neurological deficit

(2009) Anetta Undas et al.   THROMBOSIS RESEARCH

High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE)

(2008) A. M. Chamberlain et al.   BLOOD

Cardiovascular Risk Factors and Venous Thromboembolism

(2007) Walter Ageno et al.   CIRCULATION